BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 9332763)

  • 1. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
    Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between pregnancy and human papilloma virus prevalence.
    Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
    Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer.
    Ogunbiyi OA; Scholefield JH; Robertson G; Smith JH; Sharp F; Rogers K
    Obstet Gynecol; 1994 Feb; 83(2):212-6. PubMed ID: 8290182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
    Tsukui T; Hildesheim A; Schiffman MH; Lucci J; Contois D; Lawler P; Rush BB; Lorincz AT; Corrigan A; Burk RD; Qu W; Marshall MA; Mann D; Carrington M; Clerici M; Shearer GM; Carbone DP; Scott DR; Houghten RA; Berzofsky JA
    Cancer Res; 1996 Sep; 56(17):3967-74. PubMed ID: 8752165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
    Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
    J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer.
    Caussy D; Marrett LD; Worth AJ; McBride M; Rawls WE
    CMAJ; 1990 Feb; 142(4):311-7. PubMed ID: 2154306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
    Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB
    N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.